| Code | Description | Claims | Beneficiaries | Total Paid |
| T2023 |
Targeted case management; per month |
595 |
521 |
$193K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,440 |
2,686 |
$95K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,722 |
1,354 |
$71K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,019 |
717 |
$39K |
| H0032 |
Mental health service plan development by non-physician |
278 |
253 |
$16K |
| 90837 |
Psychotherapy, 53 minutes with patient |
191 |
121 |
$13K |
| 90791 |
Psychiatric diagnostic evaluation |
152 |
130 |
$12K |
| 80305 |
|
1,546 |
1,025 |
$12K |
| 90834 |
Psychotherapy, 45 minutes with patient |
201 |
161 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
664 |
508 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
203 |
180 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
101 |
77 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
83 |
62 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
15 |
15 |
$1K |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
19 |
12 |
$821.58 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
12 |
$405.38 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
46 |
16 |
$357.48 |
| 99406 |
|
34 |
29 |
$190.10 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
19 |
13 |
$177.87 |
| 81025 |
|
32 |
29 |
$146.79 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
19 |
15 |
$22.75 |